Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder

Journal of Affective Disorders

Volumn 103, Issue 1-3, 2007, Pages 131-138

  Pivac, Nela ^a   Knezevic, Jelena ^a   Kozaric Kovacic, Dragica ^b   Dezeljin, Martina ^a   Mustapic, Maja ^a   Rak, Davor ^b   Matijevic, Tanja ^a   Pavelic, Jasminka ^a   Muck Seler, Dorotea ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b University of Zagreb School of Medicine   (Croatia)

Author keywords

Combat related posttraumatic stress disorder; MAO B intron 13 polymorphism; Platelet MAO B activity; Psychotic symptoms

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BIOCHEMICAL MARKER;

ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DNA POLYMORPHISM; ENZYME ACTIVITY; HUMAN; INTRON; INTRON 13; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

ADULT; BLOOD PLATELETS; COMBAT DISORDERS; CROATIA; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRONS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; PSYCHOTIC DISORDERS; VETERANS;

EID: 34548855682     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.01.017     Document Type: Article

References (60)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
2. Anthenelli R.M., Tipp J., Li T.-K., Magnes L., Schuckit M.A., Rice J., Daw W., and Nurnberger Jr. J.I. Platelet monoamine oxidase activity in subgroups of alcoholics and controls: results from the collaborative study on the genetics of alcoholism. Alcohol., Clin. Exp. Res. 22 (1998) 598-604
3. Balciuniene J., Emilsson L., Oreland L., Petterson U., and Jazin E.E. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum. Genet. 110 (2002) 1-7
4. Billett E.E. Monoamine Oxidase (MAO) in human peripheral tissues. Neurotoxicology 25 (2004) 139-148
5. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Gusman F.D., Charney D.S., and Keane T.M. The development of a clinician-administered PTSD scale. J. Trauma. Stress 8 (1995) 75-90
6. Camacho A., and Dimsdale J.E. Platelets and psychiatry: lessons learned from old and new studies. Psychosom. Med. 62 (2000) 326-336
7. Cicin-Sain L., Mimica N., Hranilovic D., Balija M., Ljubin T., Makaric G., Folnegovic-Smalc V., and Jernej B. Posttraumatic stress disorder and platelet serotonin measures. J. Psychiatr. Res. 34 (2000) 155-161
8. Coccini T., Randine G., Castoldi A.F., Balloni L., Baiardi P., and Manzo L. Lymphocyte muscarinic receptors and platelet monoamine oxidase-B as biomarkers of CNS function: effects of age and gender in healthy humans. Environ. Toxicol. Pharmacol. 19 (2005) 715-720
9. Costa-Mallen P., Costa L.G., and Checkoway H. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptors TaqIB polymorphism are associated with ever-smoking status among men. Neurosci. Lett. 385 (2005) 158-162
10. Costa-Mallen P., Keleda S.N., Costa L.G., and Checkoway H. Characterization of the in vitro transcriptional activity of polymorphic alleles of the human monoamine oxidase-B gene. Neurosci. Lett. 383 (2005) 171-175
11. Davidson J., Lipper S., Kilts C.D., Mahorney S., and Hammett E. Platelet MAO in posttraumatic stress disorder. Am. J. Psychiatry 142 (1985) 1341-1343
12. Davis L.L., Suris A., Lambert M.T., Heimberg C., and Petty F. Posttraumatic stress disorder and serotonin: new directions for research and treatment. J. Psychiatry Neurosci. 22 (1997) 318-326
13. Ekblom J., Garpenstrand H., Damberg M., Chen K., Shih J.C., and Oreland L. Transcription factor binding to the core promoter of the human monoamine oxidase B gene in the cerebral cortex and in blood cells. Neurosci. Lett. 258 (1998) 101-104
14. Filic V., Vladic A., Stefulj J., Cicin-Sajn L., Balija M., Sucic Z., and Jernej B. Monoamine oxidase A and B gene polymorphism in migraine patients. J. Neurol. Sci. 228 (2005) 149-153
15. Fowler J.S., Logan J., Wang G.J., and Volkow N.D. Monoamine oxidase and cigarette smoking. Neurotoxicology 24 (2003) 75-82
16. Garpenstrand H., Ekblom J., Forslund K., Rylander G., and Oreland L. Platelet monoamine oxidase activity is related to MAOB intron 13 genotype. J. Neural Transm. 107 (2000) 523-530
17. Girmen A.S., Baenziger J., Hotamisligil G.S., Konradi C., Shalish C., Sullivan J.L., and Breakefield X.O. Relationship between platelet monoamine oxidase B activity and alleles at the MAOB locus. J. Neurochem. 59 (1992) 2063-2066
18. Glover D.A., Powers M.B., Bergman L., Smits J.A., Telch M.J., and Stuber M. Urinary dopamine and turn bias in traumatized women with and without PTSD symptoms. Behav. Brain Res. 144 (2003) 137-141
19. Geraciotti Jr. T.D., Baker D.G., Ekhotar N.N., West S.A., Hill K.K., Bruce A.B., Schmidt D., Rounds-Kugler B., Yehuda R., Keck Jr. P.E., and Kasckow J.W. CSF norepinephrine concentration in posttraumatic stress disorder. Am. J. Psychiatry 158 (2001) 1227-1230
20. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
21. Hamner M.B., and Diamond B.I. Elevated plasma dopamine in posttraumatic stress disorder: a preliminary report. Biol. Psychiatry 33 (1993) 304-306
22. Hamner M.B., and Gould P.B. Plasma dopamine beta-hydroxylase activity in psychotic and non-psychotic post-traumatic stress disorder. Psychiatry Res. 77 (1998) 175-181
23. Hamner M.B., Frueh C., Ulmer H.G., and Arana G.W. Psychotic features and illness severity in combat related veterans with chronic posttraumatic stress disorder. Biol. Psychiatry 45 (1999) 846-852
24. Hamner M.B., Robert R., and Frueh B.C. Treatment-resistant posttraumatic stress disorder: strategies for intervention. CNS Spectr. 9 (2004) 740-752
25. Hernan M.A., Checkoway H., O'Brien R., Costa-Malen P., De Vivo I., Colditz G.A., Hunter D.J., Kelsey K.T., and Ascherio A. MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD. Neurology 58 (2002) 1381-1387
26. Ho S.L., Kapadi A.L., Ramsden D.B., and Williams A.C. An allelic association study of monoamine oxidase B in Parkinson's disease. Ann. Neurol. 37 (1995) 403-405
27. Irving J.B., Coursey R.D., Buchsbaum M.S., and Murphy D.L. Platelet monoamine oxidase activity and life stress as predictors of psychopathology and coping in a community sample. Psychol. Med. 19 (1989) 79-90
28. Jansson M., McCarthy S., Sullivan P.F., Dickman P., Andersson B., Oreland L., Schalling M., and Pedersen N.L. MAOA haplotypes associated with thrombocyte-MAO activity. BMC Genetics 6 (2005) 46 10.1186/1471-2156-6-46
29. Kay S.R., Fiszbein A., and Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 13 (1987) 261-276
30. Kirk K.M., Whitfield J.B., Pang D., Heath A.C., and Martin N.G. Genetic covariation of neuroticism with monoamine oxidase activity and smoking. Am. J. Med. Genet. 105 (2001) 700-706
31. Kozaric-Kovacic D., and Pivac N. Quetiapine treatment in an open trial in combat related posttraumatic stress disorder with psychotic features. Int. J. Neuropsychopharmacol. 9 (2006) 10.1017/S1461145706006596
32. Kozaric-Kovacic D., Ljubin T., Rutic-Puz L., Mihaljevic J., Jernej B., and Cicin-Sajn L. Platelet monoamine oxidase activity, ego strength, and neuroticism in soldiers with combat related current posttraumatic stress disorder. Croat. Med. J. 41 (2000) 76-80
33. Kozaric-Kovacic D., Bajs M., Vidosic S., Matic A., Alegic Karin A., and Peraica T. Change of diagnosis of post-traumatic stress disorder related to compensation-seeking. Croat. Med. J. 45 (2004) 427-433
34. Kozaric-Kovacic D., Pivac N., Muck-Seler D., and Rothbaum B.O. Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial. J. Clin. Psychiatry 66 (2005) 922-927
35. Krajl M. A rapid microfluorimetric determination of monoamine oxidase. Biochem. Pharmacol. 14 (1965) 1683-1685
36. Lowry O.H., Rosenbrough N.S., Farr A.C., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
37. Matsumoto C., Shinkai T., Hori H., Ohmori O., and Nakamura J. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia. Psychiatry Res. 127 (2004) 1-7
38. Meszaros Z., Borsiczky D., Mate M., Tarcali J., Szombathy T., Tekes K., and Magyar K. Platelet MAO-B activity and serotonin content in patients with dementia: effect of age, medication and disease. Neurochem. Res. 23 (1998) 863-868
39. Mueller-Oerlinghausen B., Roggenbach J., and Franke L. Serotonergic platelet markers of suicidal behaviour - do they really exist?. J. Affect. Disord. 79 (2004) 13-24
40. Nemeroff C.B., Bremner J.D., Foa E.B., Mayberg H.S., North C.S., and Stein M.B. Posttraumatic stress disorder: a state-of-the-science review. J. Psychiatr. Res. 40 (2006) 1-21
41. Nicotra A., Pierucci F., Parvez H., and Senatori O. Monoamine oxidase expression during development and aging. Neurotoxicology 25 (2004) 155-165
42. Oreland L. Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection. Neurotoxicology 25 (2004) 79-89
43. Paaver M., Eensoo D., Pulver A., and Harro J. Adaptive and maladaptive impulsivity, platelet monoamine oxidase (MAO) activity and risk-admitting in different types of risky drivers. Psychopharmacology 186 (2006) 32-40
44. Pivac N., and Kozaric-Kovacic D. Pharmacotherapy of treatment-resistant combat-related posttraumatic stress disorder with psychotic features. Croat. Med. J. 47 (2006) 440-451
45. Pivac N., Muck-Seler D., Sagud M., and Jakovljevic M. Platelet serotonergic markers in posttraumatic stress disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26 (2002) 1193-1198
46. Pivac N., Kozaric-Kovacic D., and Muck-Seler D. Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related posttraumatic stress disorder. Psychopharmacology 175 (2004) 451-456
47. Pivac N., Muck-Seler D., Mustapic M., Kozaric-Kovacic D., Nenadic-Sviglin K., and Dezeljin M. Platelet monoamine oxidase in alcoholism. Psychopharmacology 182 (2005) 194-196
48. Pivac N., Kozaric-Kovacic D., Mustapic M., Dezeljin M., Borovecki A., Grubisic-Ilic M., and Muck-Seler D. Platelet serotonin in combat related posttraumatic stress disorder with psychotic symptoms. J. Affect. Disord. 93 (2006) 223-227
49. Pivac N., Knezevic J., Mustapic M., Dezeljin M., Muck-Seler D., Kozaric-Kovacic D., Balija M., Matijevic T., and Pavelic J. The lack of association between monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity among men. Life Sci. 79 (2006) 45-49
50. Ruchkin V.V., Roman A., Koposov R.A., Britt af Klinteberg B., Oreland L., and Grigorenko E.L. Platelet MAO-B, personality, and psychopathology. J. Abnorm. Psychology 114 (2005) 477-482
51. Sautter F.J., Bissette G., Wiley J., Manguno-Mire G., Schoenbachler B., Myers L., Johnson J.E., Cerbone A., and Malaspina D. Corticotrophin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biol. Psychiatry 54 (2003) 1382-1388
52. Schalling D., Asberg M., Edman G., and Oreland L. Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr. Scand. 76 (1987) 172-182
53. Sobell J.L., Lind T.J., Hebrink D.D., Heston L.L., and Sommer S.S. Screening the monoamine oxidase B gene in 100 male patients with schizophrenia: a cluster of polymorphisms in African-American but lack of functionally significant sequence changes. Am. J. Med. Genet. (Neuropsychiatric Gen.) 74 (1997) 44-49
54. Southwick S.M., Krystal J.H., Bremner D., Morgan III C.A., Nicolaou A.L., Nagy L.M., Johnson D.R., Heninger G.R., and Charney D.S. Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch. Gen. Psychiatry 54 (1997) 749-758
55. Stahl S.M. Platelets as pharmacological models for the receptors and biochemistry of monoaminergic neurons. In: Longenecker G.L. (Ed). Platelets: Physiology and Pharmacology (1985), Academic Press, New York 307-340
56. Stahl S.M. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J. Affect. Disord. 51 (1998) 215-235
57. van Praag H.M. The cognitive paradox in posttraumatic stress disorder: a hypothesis. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 (2004) 923-935
58. Vermetten E., and Bremner J.D. Circuits and systems in stress. II. Applications to neurobiology and treatment in posttraumatic stress disorder. Depress. Anxiety 16 (2002) 14-38
59. Winblad B., Gottfries C.G., Oreland L., and Wiberg A. Monoamine oxidase in platelets and brains of nonpsychiatric and non-neurological geriatric patients. Med. Biol. 57 (1979) 129-132
60. Zammit S., Jones G., Jones S.J., Norton N., Sanders R.D., Milham C., McCarthy G.M., Jones L.A., Cardno A.G., Gray M., Murphy K.C., O'Donovan M.C., and Owen M.J. Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia. Am. J. Med. Genet. B (Neuropsychiatric Gen.) 128 (2004) 19-20